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Rasayana is one of the eight branches of classical Ayurveda, used for 
prevention of diseases and prolongation of a healthy life. Rasayana are 
rejuvenators, nutritional supplements, possess strong anti-oxidant activity 
and increases Ojas. Rasayana therapy enhances the qualities of Rasa, 
enriches it with nutrients so one can attain longevity, freedom from 
diseases, youthfulness, memory, intelligence; excellence in complexion, 
lustre and sense organs; development of healthy physique and 
rejuvenation of mind and body. Present study has been designed to 
evaluate the efficacy of Amalakavleha as Rasayana in healthy individuals. 
45 individuals fulfilling the inclusion criteria were randomly selected and 
divided into two groups. In Group-I, 23 individuals were administered 
Amalakavleha and in Group-II, 22 individuals were given starch capsules 
as placebo for 8 weeks. Individuals were thoroughly assessed on various 
subjective and objective parameters during complete trial period. Group-I 
individuals showed statistically significant improvement on various 
treadmill test related parameters like exercise time, maximum work load, 
VO2 max and rate pressure product, whereas statistically insignificant 
changes in these parameters were observed in the individuals receiving 
placebo. In Group-I during TMT, exercise time increased by 8.15% and 
Group-II had a marginal increase of only 0.30%, rise of 8.97% observed in 
maximum work load attained in Group-I whereas Group-II individuals 
showed rise of 1.78%. In Group-I, Vo2 max had 4.10% rise as compared to 
Group-II, having negligible rise of 0.15%. RPP in Group-I increased by 
6.75%, while in Group-II 0.21% change was noticed. These results prove 
the efficacy and safety of Amalakavleha as Rasayana in healthy individual’s 
w.r.t. physical and mental health. No untoward effects of therapy were 
observed in study subjects during the entire trial period.  
 
INTRODUCTION
Longevity is one of the primary instincts 
which are common among all living creatures. But 
there is no use of long life if a person is not healthy 
as quality of life is important for an individual. In 
today’s competitive world, the erroneous life style 
is resulting in progressive decline in both physical 
and mental health. Sedentary life style super added 
with faulty eating patterns has led to marked 
reduction in health of individuals, which has 
resulted in a high incidence of various non 
communicable diseases. Ayurveda, an ancient 
science of life, developed through the ages, deals 
with physical, psychological as well as spiritual well 
being of an individual. It is not just the knowledge of 
medicine but the complete science of life.  
 “Swasthasya Swasthya Rakshanam”[1] means 
maintaining the health of a healthy person had been 
the prime aim of Ayurveda. In Ayurveda emphasis 
has been given to preventive aspect of health 
considering physical, mental, and social aspects 
rather treating a disease. To achieve this goal, daily 
regimen, seasonal regimen, code of conduct of diet 
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and social behaviour are mentioned in Ayurveda. 
Rasayana, which is one of the unique disciplines of 
Ayurveda, comprises a specialized use of herbs, 
herbo-mineral formulations, food articles, and 
lifestyle along with self-discipline and social 
etiquette to achieve the optimum state of tissues 
and systems of the body so that there is the least 
possibility of onset of disease. Rasayana is a 
specialized modality influencing the fundamental 
aspects of body viz. Dhatu, Agni, Srotas, Ojas. A 
person undergoing Rasayana or rejuvenation 
therapy attains longevity, memory, intellect, 
freedom from diseases, lustre of skin, excellent 
potency of body, good strength and good 
functioning of sense organs. Looking at the 
multifaceted approach of Rasayana, it can be said 
that Rasayana therapy incorporates various forms 
of health promotive activities in the form of diet, 
lifestyle, or medicines which target at achieving 
homeostasis (Dhatu Samya) thus retarding the 
process of aging, used to prevent diseases, 
promotion and prolongation of healthy life and not 
merely treating the disease. 
The amalgamation of healthy living style 
and use of Rasayana can immensely help the 
mankind in preventing various diseases. Rasayana 
is having a replenishing effect on all the body 
tissues, organs and organ systems of the body.  
AIMS AND OBJECTIVES 
Primary Objective 
To evaluate the efficacy of Amalakavleha as 
Rasayana in healthy individuals w.r.t general 
physical and mental fitness. 
Secondary Objective 
To assess the safety of Amalakavleha in 
healthy individuals when used as Rasayana w.r.t 
general physical and mental fitness. 
Protocol of Research 
1. IEC Approval: Approval of Institutional Ethical 
Committee was obtained before 
commencement of research work vide Letter 
No.- Ayu/IEC/2017/1137 dated 01/09/2018. 
2. CTRI Registration: The study has also been 
registered in Clinical Trial Registry of India 
(CTRI) vide CTRI No.– CTRI/2019/09/021387 
dated 23/09/2019, prospectively. 
3. Consent: Written and informed consent of 
healthy volunteers was taken before inclusion 
in the trial. 
4. Case Record Proforma: A detailed case record 
proforma was prepared before commencement 
of interventional drug and after completion of 
therapy. 
MATERIALS AND METHODS  
Selection of the Individuals 
 A total of 45 study subjects were selected 
from OPD/campus of R.G.G.P.G. Ayurvedic College 
and Hospital, Paprola, District Kangra (H.P.) 
irrespective of caste, sex, race and religion. A 
detailed history of study subjects was obtained, 
physical examination was conducted and relevant 
investigations were carried out before the 
enrolment and after the completion of trial period. 
Inclusion Criteria 
1. Healthy volunteers who were willing to 
undergo the clinical trial. 
2. Individuals of either gender aged between 30–
60 years. 
3. Individuals who were able to participate for 8 
weeks of duration. 
Exclusion Criteria 
1. Individuals who were not willing to undergo the 
treatment. 
2. Individuals below 30 years and above 60 years 
of age. 
3. History of hypersensitivity to the treatment 
drug or any of its ingredients.  
4. Individuals who completed participation in any 
other clinical trial during the past six months. 
5. Any other condition which the principal 
investigator thought may jeopardize the study. 
Laboratory Investigations 
Hb%, TLC, DLC, ESR, FBS, Blood urea, Serum 
creatinine, SGOT, SGPT, S.Lipid profile (S. 
Cholesterol, S. Triglycerides, HDL, LDL, VLDL), 
S.Proteins. 
Grouping of the Study Subjects 
Selected study subjects were randomly 
divided into following two groups. 
Group I: In this group 23 study subjects were 
registered out of which two discontinued the 
treatment and 21 individuals completed the study. 
In this group study subjects were given 
Amalakavleha in dose of 10gm once in a day (in 
morning) with Koshana Jala. Kohstha shuddhi was 
done before commencement of Rasayana 
formulation i.e., Amalakavleha by administrating 
Haritakayadi Yoga in dose of 5g with lukewarm 
water at bed time for 3-7days according to Koshtha.  
Group II: In this group 22 study subjects were 
given starch capsules (500mg once in a day) as 
placebo out of which two were drop out and only 20 
individuals completed the study. 
Apart from this, the individuals in both 
groups were asked to have a brisk walk of 30 
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minutes daily in the morning, Pranayama for 5 to10 
minutes, low calorie, low sodium and low fat diet. 
Duration of treatment: 8 Weeks 
Route of administration: Oral 
Trial Drugs 
 Interventional products were prepared at 
Government Charaka Ayurvedic Pharmacy, Paprola 
vide Licence No. HP-Ay-87. 
Amalakavleha[2] 
Table1: Ingredients of Amalakavleha 
Ingredients Botanical Name Family Part used 
Amalaki Emblica officinalis Euphorbiaceae Pericarp 
Pippali Piper longum Piperaceae Fruit 
Palash kshara Butea monosperma Fabaceae – 
Madhu (Honey) – – – 
Go-Ghrita (Ghee) – – – 
Sharkara – – – 
Haritakayadi Yoga[3] 
Table 2: Ingredients of Haritakayadi Yoga 
Ingredients Botanical Name Family Part used Ratio 
Haritaki Terminalia chebula Combretaceae Pericarp 1 
Amalaki Emblica officinalis Euphorbiaceae Pericarp 1 
Vacha Acorus calamus Acoraceae Rhizome 1 
Haridra Curcuma longa Zingiberaceae Rhizome 1 
Vishavbhaishaja Ziingiber officinale Zingiberaceae Rhizome 1 
Vidanga Embelia ribes Myrsinaceae Fruit 1 
Pippali Piper longum Piperaceae Fruit 1 
Saindhav lavana 
(Himalayan rock salt) 
– – – 1 
Guda (Jaggery) – – – 1 
Follow up and Assessment of the Study Subjects 
A thorough assessment of the study subjects was done before commencement of the therapy (day 
zero) and at the 14th, 28th, 42nd and 56th day i.e. at the time of the completion of therapy. The effects of 
treatment were assessed on the basis of various subjective and objective parameters. Laboratory 
investigations were carried out before commencement and after completion of the treatment. 
ASSESSMENT CRITERIA 
Objective criteria 
1. TMT related parameters like- Exercise time, Maximum work load attained in terms of Mets, VO2 max, 
Double product/RPP (Rate Pressure Product). 
2. Body weight 
3. BMI 
4. Vital capacity 
5. Foot thrust 
6. Hand grip power 
Subjective criteria 
An elaborated Proforma for the assessment of general health was used for the assessment of 
subjective criteria (Individual questionnaire, Rotation–A, World Health organization evidence and 
information for policy, World Health Survey 2002). This questionnaire covered all those important aspects 
with which individuals often struggle like- Overall health, Self care, Sleep, Mobility, Cognition, Interpersonal 
activities etc. Subjective criteria of assessment were graded from 0 to 4. 
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Table 3: Grading of subjective Criteria 
Sr. No. Symptoms Grade 
1. Overall Health 
In general how would you rate your health today? 
 Very good G0 
 Good G1 
 Moderate G2 
 Bad G3 
 Very Bad G4 
2. Overall in the last 30 days how much difficulty did you have with you work or 
household activities? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
3. Mobility 
Overall in the last 30 days how much difficulty did you have in vigorous activities such 
as running 3km or cycling? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
4. Self Care 
Overall in the last 30 days how much difficulty did you have with self care as washing or 
dressing yourself? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
5. Overall in the last 30 days how much difficulty did you have in taking care of and 
maintaining your general appearance (grooming, looking neat and tidy etc.)? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
6. Pain and Discomfort 
Overall in the last 30 days how much of bodily aches or pain did you have? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
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7. Overall in the last 30 days how much of bodily discomfort did you have? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
8. Cognition 
Overall in the last 30 days how much difficulty did you have in concentrating or 
remembering things? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
9. Overall in the last 30 days how much difficulty did you have in learning a new task? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
10. Interpersonal Activities 
Overall in the last 30 days how much difficulty did you have in dealing with conflicts 
and tensions with others? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
11. Sleep and Energy  
Overall in the last 30 days how much difficulty did you have with sleeping, such a falling 
asleep, waking up frequently during night or waking up to early in the morning? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
12. Overall in the last 30 days how much difficulty did you have to not feeling rested and 
refreshed during the day? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
13. Affect 
Overall in the last 30 days how much difficulty did you have with feeling sad, low or 
depressed? 
 None G0 
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 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
14. Self Care 
Overall in the last 30 days how much difficulty did you have worry or anxiety? 
 None G0 
 Mild G1 
 Moderate G2 
 Severe G3 
 Extreme G4 
OBSEVATIONS AND RESULTS 
Out of 45 registered study subjects maximum were married (91%) male (64%) of age group 
between 41-50 yrs (44%) dwelling in rural area (78%) and Hindu (100%) by religion. 84% were literate 
and majority of them were involved in desk work (33%), taking vegetarian diet (53%), having reduced sleep 
(49%) and appetite (66.6%). 88% of study subjects had no addiction but rest of them were addicted either 
to smoking or alcohol. Majority of individuals had Vata-Kaphaj Deha Prakriti (42.22%) and Rajsik Manas 
Prakriti (44.44%). Majority were Meda Sara (35.55%) with Madhyama Samhanana (57.77%), Satva 
(51.11%), Satmaya (62.22%), Pramana (53.33%) and Avara Aahara Shakti (53.33%) and Avara Vyayama 
Shakti (42.22%). 
Table 4: Assessment of Effects on TMT parameters 
Variable Group  Mean Score  Percent 
Change  BT AT 
Exercise time (In minutes) Group-I 8.58  9.28  8.15%  
Group-II 6.56  6.54  0.30%  
Max Work load (METS) (In term of Mets) Group-I 10.19  11.11  8.97% 
Group-II 9.88  9.71  1.78% 
VO2 Max (In ml/kg/ min) Group-I 36.25  37.75  4.10% 
Group-II 34.41  34.47  0.15% 
RPP (In mm Hg. Hz) Group-I 24603.20  23045.63  6.33% 
Group-II 22152.57  22106.05  0.21% 
Table 5: Statistical Analysis on Effects of Therapy on TMT Parameters 
Variable Group Mean 
Diff.  






Exercise time (In 
minutes) 
Group-I 0.70  1.78  0.49  4.452  0.009 (<0.01)  0.008 
Group-II 0.02  2.34  0.33  0.111  0.224 (>0.05)  
Max Work load (METS) 
(In term of Mets) 
Group-I 0.92  1.19  0.27  3.437  0.003 (<0.01) 0.001 
Group-II 0.18  0.64  0.14  1.255 0.224 (>0.05) 
VO2 Max (In 
ml/kg/min) 
Group-I 1.50  2.27  0.51  2.946 0.008 (<0.01) 0.007 
Group-II 0.06  0.48  0.10  0.519 0.610 (>0.05) 
RPP (In mm Hg. Hz) Group-I 1557.57  2343.39  523.99  3.303 0.004 (<0.01) 0.004 
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Table 6: Assessment Result on Other Objective Parameters 
Variable Group  Mean Score  Percent 
Change  BT AT 
Vital Capacity (In Litre) 
 
Group-I 3.54  3.59  1.32% 
Group-II 3.35   3.36  0.29% 
Foot Thrust (In Kg) Group-I 65.60  66.90  1.98% 
Group-II 61.81  60.91  0.15% 
Hand Grip Power (In mm of Hg) Group-I 92.50  95.95  3.72% 
Group-II 94.60  93.75  0.90% 
Body Weight (In Kg) Group-I 65.80  65.81  0.01% 
Group-II 63.14  63.08  0.10%  
BMI (In Kg/m2) Group-I 22.36  22.37  0.02% 
Group-II 22.13  22.11  0.06% 
Table 7: Statistical Analysis on Other Objective Parameters 
Variable Group Mean 
Diff.  
SD+  SE+   ‘t’ value  ‘p’  value  Intergroup 
p-value 
Vital Capacity (In 
Litre) 
Group-I 0.05  0.18  0.05  3.425  0.007 (<0.01)  0.050 
Group-II 0.01  0.20  0.05  0.611  0.321 (>0.05)  
Foot Thrust (In Kg) Group-I 1.30  1.59  0.36  3.650 0.002 (<0.01) 0.010 
Group-II 0.01  1.55  0.34  0.282 0.781 (>0.05) 
Hand Grip Power (In 
mm of Hg) 
Group-I 3.450  3.83  0.86  4.027 0.001 (<0.001)  0.010 
Group-II 0.850  2.78  0.62  1.369 0.187 (>0.05)  
Body Weight (In Kg) Group-I 0.01  0.45  0.10  0.049 0.961 (>0.05) 0.682 
Group-II 0.06  0.43  0.09  0.659 0.518 (>0.05) 
BMI (In Kg/m2) Group-I 0.01  0.20  0.05  1.448 0.164 (>0.05) 0.180 
Group-II 0.02  0.17  0.04  0.396 0.697 (>0.05) 
Table 8: Assessment Result on Subjective Parameters 
Variable Group  Mean Score  Percent 
Change   BT AT 
Overall Health 
 
Group-I 2.95  2.00  32.20% 
Group-II 2.91  2.81 3.09% 
Mobility Group-I 3.05  4.16  36.30% 
Group-II 1.95  2.06  5.60% 
Self Care Group-I 2.80 2.56  11.40%  
Group-II 2.95 2.81  4.80%  
Cognition Group-I 2.90  2.10  27.50% 
Group-II 3.14  3.00  4.45% 
Interpersonal Activities Group-I 3.00  1.90  36.60% 
Group-II  3.10  2.91  6.10%  
Sleep Group-I 2.95  1.90  35.50%  
Group-II 2.91  2.81  3.30%  
Energy Group-I 2.85  2.15  24.50% 
Group-II 2.76  2.81  1.70% 
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Table 9: Statistical analysis on subjective parameters 
Variable Group Mean 
Diff.  








Group-I 0.95  1.47  0.33  2.894 0.009 (<0.01) 0.010 
Group-II 0.10  0.30  0.07  1.451 0.162 (>0.05) 
Mobility Group-I 1.11  1.71  0.38  2.871 0.010 (<0.01) 0.636 
Group-II 0.11  1.24  0.27  1.234 0.232 (>0.05) 
Self Care Group-I 0.33  0.28  0.29  1.679 0.061 (>0.05) 0.684 
Group-II 0.14  0.36  0.08  1.826 0.083 (>0.05) 
Cognition Group-I 0.80  1.32  0.29  2.707 0.014 (<0.01) 0.722 
Group-II 0.14  1.28  0.27  1.195 0.246 (>0.05) 
Interpersonal 
Activities 
Group-I 1.10  1.45  0.32  3.399 0.003 (<0.01) 0.023 
Group-II 0.19  0.98  0.21  0.890 0.384 (>0.05) 
Sleep Group-I 1.05  1.43  0.32  3.280 0.004 (<0.01) 0.005 
Group-II 0.10  0.30  0.07  1.451 0.162 (>0.05) 
Energy Group-I 0.70  1.30  0.29  2.405 0.027 (<0.01) 0.025 
Group-II 0.05  0.67  0.15  0.326 0.748 (>0.05) 
Table 10: Assessment Results of Effects of Therapy on Laboratory Parameters 
Variable Group  Mean Score  Percent 
Change   BT AT 
Hb 
 
Group-I 12.77 12.81 0.31% 
Group-II 11.98 11.87 0.95% 
TLC Group-I 7097.50 7099.00 0.02% 
Group-II 7171.42 7170.38 0.01% 
Neutrophils Group-I 58.86 59.57 1.20% 
Group-II 23.54 23.72 0.76% 
Mixed cells Group-I 9.18 9.22 0.38% 
Group-II 12.87 12.81 0.46% 
Lymphocytes Group-I 31.40 31.85 1.41% 
Group-II 24.49 24.50 0.02% 
ESR Group-I 20.00 19.26 3.72% 
Group-II 13.33 13.32 0.13% 
FBS Group-I 94.90 93.65 1.31% 
Group-II 92.38 94.00 1.75% 
B. Urea 
 
Group-I 23.20 23.12 0.36% 
Group-II 31.43 31.44 0.01% 
S. Creatinine Group-I 0.93 0.91 1.62% 
Group-II 0.98 0.97 0.61% 
S. Cholesterol Group-I 176.60 174.20 1.35% 
Group-II 166.57 166.85 0.16% 
S. Triglycerides Group-I 135.75 134.25 1.10% 
Group-II 133.38 133.79 0.31% 
HDL Group-I 55.11 56.00 1.64% 
Group-II 67.91 67.38 0.77% 
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LDL Group-I 93.27 92.11 1.24% 
Group-II 101.38 102.14 0.75% 
VLDL Group-I 29.18 28.77 1.41% 
Group-II 27.54 27.75 0.76% 
SGOT 
 
Group-I 35.46 33.84 4.56% 
Group-II 35.24 35.20 0.11% 
SGPT Group-I 38.00 36.94 2.79% 
Group-II 34.57 34.33 0.70% 
S. Proteins Group-I 6.95 7.01 0.81% 
Group-II 6.81 6.80 0.14% 
Table 11: Statistical Analysis on Laboratory Parameters 
Variable Group Mean 
Diff.  
SD+  SE+   ‘t’ 
value  




Group-I 0.04 0.04 0.07 0.577 0.571 (>0.05) 0.478 
Group-II 0.11 0.35 0.07 1.492 0.151 (>0.05) 
TLC Group-I 1.50 1953.57 436.83 0.235 0.817 (>0.05) 0.376 
Group-II 1.04 1399.61 305.42 1.887 0.151 (>0.05) 
Neutrophils Group-I 0.71 14.08 3.15 0.581 0.568 (>0.05) 0.765 
Group-II 0.18 5.81 1.27 0.682 0.522 (>0.05) 
Mixed cells Group-I 0.04 5.04 1.13 0.218 0.830 (>0.05) 0.661 
Group-II 0.06 3.91 0.85 0.441 0.664 (>0.05) 
Lymphocytes Group-I 0.45 12.27 2.74 0.162 0.873 (>0.05) 0.949 
Group-II 0.01 4.92 1.07 0.242 0.811 (>0.05) 
ESR Group-I 0.74 10.04 2.25 1.292 0.212 (>0.05) 0.873 
Group-II 0.01 8.69 1.89 1.281 0.220 (>0.05) 
FBS Group-I 1.25 16.40 3.67 1.159 0.261 (>0.05) 0.530 
Group-II 1.62 9.47 2.07 0.784 0.442 (>0.05) 
B. Urea 
 
Group-I 0.08 5.36 1.19 0.901 0.372 (>0.05) 0.604 
Group-II 0.01 6.42 1.40 1.871 0.075 (>0.05) 
S. Creatinine Group-I 0.02 0.18 0.04 1.580 0.131 (>0.05) 0.298 
Group-II 0.01 0.34 0.07 2.025 0.056 (>0.05)  
S. Cholesterol Group-I 2.40 32.47 7.26 1.818 0.085 (>0.05)  0.197 
Group-II 0.28 13.82 3.02 1.011 0.393 (>0.05) 
S. Triglycerides Group-I 1.50 40.12 8.97 1.789 0.090 (>0.05) 0.189 
Group-II 0.41 12.55 2.74 1.373 0.180 (>0.05)  
HDL Group-I 0.89 8.35 1.87 0.565 0.576 (>0.05) 0.898 
Group-II 0.53 5.22 1.14 1.171 0.255 (>0.05) 
LDL Group-I 1.16 36.45 8.15 0.871 0.395 (>0.05) 0.473 
Group-II 0.76 16.32 3.56 0.124 0.833 (>0.05)  
VLDL Group-I  0.41 13.26 3.10 0.360 0.723 (>0.05) 0.682 
Group-II 0.21 11.32 2.47 0.208 0.837 (>0.05) 
SGOT 
 
Group-I 1.619 3.83 0.86 1.652 0.710 (>0.05) 0.364 
Group-II 0.038 18.48 4.03 0.106 0.916 (>0.05) 
SGPT Group-I 1.063 21.88 5.02 0.650 0.521 (>0.05) 0.603 
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Group-II 0.242 6.88 1.50 0.704 0.493 (>0.05) 
S. Proteins Group-I 0.06 0.50 0.12 1.133 0.270 (>0.05) 0.061 
Group-II 0.01 0.49 0.11 1.604 0.120 
DISCUSSION 
The present clinical study was aimed to 
assess the efficacy and safety of Amalakavleha as 
Rasayana in healthy individuals.  
Among treadmill test parameters it was 
observed that after the completion of eight weeks of 
therapy the mean value of duration of exercise in 
Group-I increased from 8 min 58 sec to 9 min 28 sec 
with an increase of 8.15%, mean value of Max. Work 
Load attained before the treatment was 10.195 
Mets which increased to 11.11 Mets after the 
completion of therapy with 8.97% increase, mean 
value of VO2 Max before treatment was 36.251ml/ 
kg/min which increased to 37.749ml/kg/min with 
an increase of 4.10%, RPP before treatment was 
23045.63mmHg. Hz which increased to 
24603.2mmHg. Hz after treatment with 6.75% rise. 
All the results were statistically significant (p <0.01) 
in Group-I and in Group-II mean value of exercise 
time before treatment was 6 min 56 sec which 
reduced to 6 min 54 sec after the completion of 
therapy with a decline of 0.30%, mean value of Max. 
Work Load attained before the administration of 
treatment was 9.881 Mets which decreased to 9.705 
Mets after completion of therapy with change of 
1.78%, mean value of Vo2 increased from 
34.414ml/kg/min to 34.468ml/kg/min. with a 
negligible increase i.e. 0.15%, mean value of RPP 
before treatment was 22106.05mmHg. Hz which 
increased to 22152.57mmHg. Hz after the 
completion of therapy with a change of 0.21%. All 
the results were statistically insignificant (p >0.05) 
in Group-II (Table No.-4) 
The intergroup comparison of effect of 
therapy on all TMT parameters revealed a 
statistically significant difference (‘p’ <0.01). (Table 
No.-4) 
Among 20 study subjects registered under 
Group–I the mean value of foot thrust before 
treatment was 65.60Kg which increased to 66.90Kg 
after treatment with an increase of 1.98% which 
was statistically significant and among 21 study 
subjects registered under Group–II, the mean value 
of foot thrust before treatment was 61.81Kg which 
decreased to 60.91Kg after the completion of 
therapy with a change of 0.15% which was 
statistically insignificant (p >0.05). Mean value of 
hand grip power in Group-I increased to 95.95 mm 
of Hg from 92.50mm of Hg with an increase of 
3.72% which was statistically significant and in 
Group–II, it was found that the mean value of hand 
grip power decreased to 93.75mm of Hg from 
94.60mm of Hg with a change of 0.90% which was 
statistically insignificant. In Group–I mean value of 
body weight before treatment was 65.80Kg which 
increased to 65.81Kg after treatment with a 
negligible change of 0.01% and in Group–II, the 
mean value of body weight decreased from 63.14Kg 
to 63.08Kg with a change of 0.1%. However the 
results were statistically insignificant in both the 
groups. In Group–I the mean value of BMI increased 
negligibly (0.02%) from 22.36Kg/m2 to 22.37Kg/m2 
and results found were statistically insignificant. In 
Group–II also statistically insignificant reduction in 
the mean value of BMI was observed i.e. from 
22.13Kg/m2 to 22.12Kg/m2 with decline of 0.06%. 
In order to assess the respiratory endurance the 
study subjects were asked to perform the 
spirometery test and in Group–I vital capacity 
showed statistically significant increase of 1.32% 
with rise in mean value from 3.54L to 3.59L and in 
Group–II change of 0.29% was observed with 
increase in mean value from 3.35L to 3.36L which 
was statistically insignificant (Table No.-5) 
Intergroup comparison of foot thrust and 
hand grip power revealed statistically significant 
difference whereas, intergroup comparison of body 
weight, BMI and vital capacity showed statistically 
insignificant difference (Table No.-5). 
In the present study, WHO questionnaire 
was adopted for the assessment of subjective 
parameters (Table No.-3). It was observed that 
statistically significant improvement was obtained 
on overall health (32.2%) and energy (24.5%) in 
Group-I. Group-II which was the placebo group 
showed statistically insignificant results both for 
overall health (3.09%) as well as for energy 
(1.70%). Statistically significant results were 
obtained in Group-I on parameters like 
interpersonal activities (36.6%), mental status 
(29.6%) and sleep (35.5%). However Group-II 
showed statistically insignificant results for all 
these mentioned parameters (Table No-6). The 
effect of therapy on cognition had statistically 
significant results in Group-I (27.5%) and 
statistically insignificant results in Group-II 
(4.45%). The statistical analysis of the effect of 
therapy on self care revealed that both the groups 
had statistically insignificant results but the 
improvement in Group-I (11.4%) was better than 
Group-II (4.8%). Effect of therapy on mobility 
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showed statistically significant results in Group-I 
with improvement of 36.30% whereas Group-II 
(5.60%) revealed statistically insignificant results. 
Hence statistical analysis of the data showed 
significant improvement in parameters like overall 
health, sleep, energy, interpersonal activities, 
mobility, and mental status in Group –I, where as 
statistically insignificant results were obtained in 
the parameters like self care, cognition in both 
groups. The intergroup comparison showed 
statistically significant difference on overall health, 
sleep, energy, interpersonal activities and mental 
status and statistically insignificant results on 
mobility, cognition and self care (Table No.-6). 
Various laboratory investigations including 
Hb, TLC, DLC, ESR, FBS, Blood urea, Serum 
creatinine, SGOT, SGPT, S. Lipid profile (S. 
Cholesterol, S. Triglycerides, HDL, LDL, VLDL), S. 
Proteins were within normal range both before and 
after the therapy in both the groups and statistically 
insignificant changes were observed in these Lab. 
parameters in both the groups after the therapy. 
(Table No. 7) 
The above results showed positive changes 
in Group-I in which Amalakavleha was 
administered as Rasayana which contains Amalaki, 
Pippali, Go-Ghrita etc. (Table No.-1). Amalaki is 
commonly used drug in Ayurveda to promote 
longevity.[4] It has been considered as a very good 
Rasayana. Amalaki has Madhuar Rasa, Guru Guna, 
Sheeta Veerya and Madhura Vipaka which helps in 
the formation of Rasa of the best Quality.[5] This 
Rasa further helps in the formation of excellent 
Dhatus which further promotes our physical fitness 
and overall health. Its Amla, Madhura, Katu, Tikta, 
Kashaya Rasa and Sheeta, Ruksha guna makes it 
superior fruit among all fruits.[6] It helps in 
amplification of Agni[7]; Augmented Agni removes 
the Ama from body, improves the metabolism, helps 
in Strotoshodhana[8] that further helps the Rasa to 
nourish Dhatus properly, leading to formation of 
Ojas[9]. Amalaki has a variety of flavonoids, 
abundance of Vit C, iron, phosphorous which helps 
in the better functioning of enzymatic reactions and 
hence helps in improving overall health and boost 
up our energy. It has tannoids, gallic acid, ellagic 
acid, corilagin which not only reduce the oxidative 
stress in the body but also possess cardioprotective 
activities.[10] It also helps in improving the memory 
and intellect by enhancement of gabaminergic 
metabolic activity.[11] 
Pippali is one of the Rasayana drugs which 
specifically act at the level of Jatharagni and 
Dhatvagni.[12] It promotes longevity, strengthens the 
immune system and reduces oxidative stress.[13] It 
has Katu Rasa and Ushana Guna acting at the level 
of Agni[12], which further embellishes the 
metabolism leading to an improved structural and 
functional pattern of Dhatus. Pippali has the 
capacity to mitigate the Agnidushti by its Deepana, 
Pachana,[13] Vrinhana, Shodhana Karma and hence 
plays an important role in release of metabolic heat 
energy. Pippali has Madhuar Vipaka[12] that 
promotes the nutritional value of Rasa which 
further helps in the formation of best quality 
Dhatus[14] and finally Ojas, which is the main 
immune-modulator in the body. Pippali also 
alleviates vitiated Vata Dosha[13], which is 
responsible for degenerative changes in body thus 
protecting body from oxidative stress. It contains 
Piperine, Piplartine, Piper legumine as primary 
constituents. Additional active chemicals includes 
several piperidine alkaloids, terpenines, sesamine 
etc. which makes it powerful stimulant of various 
systems of body like digestive, respiratory 
system.[15] Significant protection against oxidative 
stress and cardiotoxicity by virtue of its antioxidant 
activity was also concluded.[16] Its adaptogenic 
property helps our body to adapt to various 
physical and mental stress.[17] The ethanol extract of 
the P. longum fruit yields antihyperlipidemic 
activity.[18] Pippali also acts as brain tonic,[19] 
antidepressant activity of Piper longum has been 
also reported in some studies. 
Ghrita has Madhura Rasa, Guru, Snigdha, 
Sheeta Guna, Sheeta Veerya and Madhura Vipaka.[20] 
By virtue of these properties it acts as tissue 
enhancer, Medhya, Balya, Ayushya, Ojovardhaka, 
Rasayana, Vayaasthapka.[21] Agni Deepana action 
due to Prabhava of Ghee vitalizes the metabolism. 
Traditional texts also designate Cow Ghee as a 
Medhya Rasayana beneficial for mental alertness 
and memory.[20] It also possess antioxidant, immune 
modulator activities, and promotes longevity[21]. 
Honey (Madhu) has Madhura and Kashaya 
Rasa, Ruksha Guna, Sheeta Virya which helps in 
Tridosha Shamana[22] and hence balances the pillars 
of body i.e., Vata, Pitta, Kapha. Due to Ruksha Guna 
and Lekhana Karma honey penetrates micro 
channels and cleanses the channels for better 
circulation of Rasa. Honey nourishes the body with 
its Vrinhana Guna. Natural honey contains 
flavonoides such as apigenin, pinocembrin, 
quercetin and heopertin etc, phenolic acid (such as 
ellagie, caffieic, P-coumaric & ferulic acids) ascorbic 
acid, tocopherols, catalase, superoxide dismutase, 
reduced glutathione. Anti-oxidant activity of honey 
is determined by vitamin C, monophenolios, 
flavonoids and polyphenolies. Phenolic compound 
present in honey has promising cardioprotective 
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effect.[23] It assists the building and development of 
entire central nervous system which leads to the 
improvement of memory and growth, reduction of 
anxiety and enhancement of intellectual 
performance.[24] Anti- ageing potency of honey in 
white Whister albino rats was also studied which 
suggested that honey consumption may augment 
defence mechanism against oxidative stress and 
various attenuated free radicals.[25] 
CONCLUSION 
The trial drug showed promising 
improvement on various subjective and objective 
parameters related to physical and mental health. 
Statistically significant improvement in various 
TMT parameters like exercise time, maximum work 
load attained, Vo2 max, RPP and vital capacity was 
noticed in the individuals who were treated with 
Amalakavleha as compared to the placebo group. 
Statistically significant improvement in most of the 
subjective parameters like overall health, energy, 
mobility, sleep, interpersonal activities and mental 
status were also observed in the individuals who 
were given Amalakavleha as compared to the 
individuals receiving placebo.  
Hence we may conclude that Amalakavleha 
Rasayana is effective in increasing the general 
physical and mental fitness of an individual. 
No untoward effect of therapy was seen 
during the entire trial period. Though the results of 
this study are encouraging, a multi-centric study 
with larger sample size should be conducted to 
further establish the efficacy of drug. Longer 
duration trial can be done to evaluate the safety of 
drug in long term use. 
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